Cannabinoids and endocannabinoids as therapeutics for nervous system disorders:preclinical models and clinical studies

被引:0
|
作者
R.Scott Duncan [1 ]
Sean M.Riordan [1 ]
Matthew C.Gernon [1 ]
Peter Koulen [1 ,2 ]
机构
[1] Department of Ophthalmology, School of Medicine, University of Missouri
[2] Department of Biomedical Sciences, School of Medicine, University of Missouri
基金
美国国家卫生研究院;
关键词
D O I
暂无
中图分类号
R741 [神经病学];
学科分类号
1002 ;
摘要
Cannabinoids are lipophilic substances derived from Cannabis sativa that can exert a variety of effects in the human body. They have been studied in cellular and animal models as well as in human clinical trials for their therapeutic benefits in several human diseases. Some of these include central nervous system(CNS) diseases and dysfunctions such as forms of epilepsy, multiple sclerosis, Parkinson’s disease, pain and neuropsychiatric disorders. In addition, the endogenously produced cannabinoid lipids, endocannabinoids, are critical for normal CNS function, and if controlled or modified, may represent an additional therapeutic avenue for CNS diseases. This review discusses in vitro cellular, ex vivo tissue and in vivo animal model studies on cannabinoids and their utility as therapeutics in multiple CNS pathologies. In addition, the review provides an overview on the use of cannabinoids in human clinical trials for a variety of CNS diseases. Cannabinoids and endocannabinoids hold promise for use as disease modifiers and therapeutic agents for the prevention or treatment of neurodegenerative diseases and neurological disorders.
引用
收藏
页码:788 / 799
页数:12
相关论文
共 50 条
  • [31] Strategies for delivery of therapeutics into the central nervous system for treatment of lysosomal storage disorders
    Muro, Silvia
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2012, 2 (03) : 169 - 186
  • [32] Strategies for delivery of therapeutics into the central nervous system for treatment of lysosomal storage disorders
    Silvia Muro
    Drug Delivery and Translational Research, 2012, 2 : 169 - 186
  • [33] Recent trends in the development of hydrogel therapeutics for the treatment of central nervous system disorders
    Li, Qing
    Shao, Xinxin
    Dai, Xianglin
    Guo, Qiong
    Yuan, Bolei
    Liu, Ying
    Jiang, Wei
    NPG ASIA MATERIALS, 2022, 14 (01)
  • [34] Targeted Delivery of Nano-Therapeutics for Major Disorders of the Central Nervous System
    Huile Gao
    Zhiqing Pang
    Xinguo Jiang
    Pharmaceutical Research, 2013, 30 : 2485 - 2498
  • [35] Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system
    Aymerich, Maria S.
    Aso, Ester
    Abellanas, Miguel A.
    Tolon, Rosa M.
    Ramos, Jose A.
    Ferrer, Isidre
    Romero, Julian
    Fernandez-Ruiz, Javier
    BIOCHEMICAL PHARMACOLOGY, 2018, 157 : 67 - 84
  • [36] Recent trends in the development of hydrogel therapeutics for the treatment of central nervous system disorders
    Qing Li
    Xinxin Shao
    Xianglin Dai
    Qiong Guo
    Bolei Yuan
    Ying Liu
    Wei Jiang
    NPG Asia Materials, 2022, 14
  • [37] Animal models for autoimmune demyelinating disorders of the nervous system
    Gold, R
    Hartung, HP
    Toyka, KV
    MOLECULAR MEDICINE TODAY, 2000, 6 (02): : 88 - 91
  • [38] Sex representation in neurodegenerative and psychiatric disorders' preclinical and clinical studies
    DuMont, Mieke
    Agostinis, Alyssa
    Singh, Kiran
    Swan, Evan
    Buttle, Yvonne
    Tropea, Daniela
    NEUROBIOLOGY OF DISEASE, 2023, 184
  • [39] Influence of the inflammasome complex on psychiatric disorders: clinical and preclinical studies
    Kwon, Sunghark
    Cheon, So Yeong
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2021, 25 (10) : 897 - 907
  • [40] MODELS FOR PRECLINICAL STUDIES IN AGING-RELATED DISORDERS: ONE IS NOT FOR ALL
    Santulli, Gaetano
    Borras, Consuelo
    Bousquet, Jean
    Calza, Laura
    Cano, Antonio
    Illario, Maddalena
    Franceschi, Claudio
    Liotta, Giuseppe
    Maggio, Marcello
    Molloy, William D.
    Montuori, Nunzia
    O'Caoimh, Ronan
    Orfila, Francesc
    Rauter, Amelia P.
    Santoro, Aurelia
    Iaccarino, Guido
    TRANSLATIONAL MEDICINE AT UNISA, 2015, 13 : 4 - 12